Suppr超能文献

用于脊柱立体定向放射治疗患者生存分层的脊柱转移预后指数(PRISM)的内部验证。

Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery.

作者信息

Jensen Garrett, Tang Chad, Hess Kenneth R, Bishop Andrew J, Pan Hubert Y, Li Jing, Yang James N, Tannir Nizar M, Amini Behrang, Tatsui Claudio, Rhines Laurence, Brown Paul D, Ghia Amol J

机构信息

Baylor College of Medicine, Houston, Texas, USA.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

J Radiosurg SBRT. 2017;5(1):25-34.

Abstract

PURPOSE

We sought to validate the Prognostic Index for Spinal Metastases (PRISM), a scoring system that stratifies patients into subgroups by overall survival.Methods and materials: The PRISM was previously created from multivariate Cox regression with patients enrolled in prospective single institution trials of stereotactic spine radiosurgery (SSRS) for spinal metastasis. We assess model calibration and discrimination within a validation cohort of patients treated off-trial with SSRS for metastatic disease at the same institution.

RESULTS

The training and validation cohorts consisted of 205 and 249 patients respectively. Similar survival trends were shown in the 4 PRISM. Survival was significantly different between PRISM subgroups (P<0.0001). C-index for the validation cohort was 0.68 after stratification into subgroups.

CONCLUSIONS

We internally validated the PRISM with patients treated off-protocol, demonstrating that it can distinguish subgroups by survival, which will be useful for individualizing treatment of spinal metastases and stratifying patients for clinical trials.

摘要

目的

我们试图验证脊柱转移预后指数(PRISM),这是一种根据总生存期将患者分层为不同亚组的评分系统。

方法和材料

PRISM先前是通过多变量Cox回归创建的,纳入的患者来自一项针对脊柱转移的立体定向脊柱放射外科(SSRS)前瞻性单机构试验。我们在同一机构对接受非试验性SSRS治疗转移性疾病的患者验证队列中评估模型校准和区分度。

结果

训练队列和验证队列分别由205例和249例患者组成。4个PRISM亚组显示出相似的生存趋势。PRISM亚组之间的生存率有显著差异(P<0.0001)。分层为亚组后,验证队列的C指数为0.68。

结论

我们对接受非方案治疗的患者进行了PRISM内部验证,表明它可以根据生存期区分亚组,这将有助于脊柱转移瘤的个体化治疗以及为临床试验对患者进行分层。

相似文献

9

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验